AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...

Vitamins? Minerals? Botanicals? Extracts? Choosing the right supplements can be confusing. An expert offers five tips to help ...

What are the key life sciences trends to watch during the second half of 2025? Evolving regulations, precision medicine, and ...

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has received Food and Drug Administration (FDA) approval for changes to the labelling ...

Backed by a $2.7 million seed round, the startup is reimagining how intelligent agents can revolutionize high-stakes ...

The Life Sciences offering follows the earlier release of QBE’s Miscellaneous Medical Liability product in 2024. That product ...

Tiziana Life Sciences’ intranasal MS candidate shows promise in open-label study Approximately 2.9 million people worldwide are living with the neurodegenerative disease Tiziana Life Sciences has ...

Top longevity scientist Eric Topol, author of the new book Super Agers, tells National Geographic which biohacks for a longer life are backed by science—and which you can skip.

Employment in the U.S. life sciences sector hit a record high in 2024, and more job growth is expected in 2025.

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, marketing, and sale of innovative treatments and therapies, including those for ...

Changes Based on Additional Pharmacokinetics Data TORRANCE, Calif., June 26, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today ...

Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, marketing, and sale of innovative treatments and therapies, including those for ...